Skip to content

Clinical trials

Phase 3 Inflammatory Bowel Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20102
20115
20121
20151
20161
20183
20201
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated5
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC4
Eli Lilly and Company3
GlaxoSmithKline2
InDex Pharmaceuticals2
Andreas Stallmach1
AstraZeneca1
Charite University, Berlin, Germany1
Janssen Biotech, Inc.1
Merck Sharp & Dohme LLC1
Ocera Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases21
Crohn Disease11
Colitis, Ulcerative9
Colitis3
Gastrointestinal Diseases2
Anemia1
Anemia, Iron-Deficiency1
Deficiency Diseases1
Fistula1
Intestinal Diseases1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.